Treatment with efficacious drugs

 Treatment with efficacious drugs (artemisinin-based combination therapy – ACT for P. falciparum and chloroquine
for other types of malaria)
 Behaviour change communications to increase awareness and to help ensure adherence to interventions
Additional tools and delivery mechanisms are needed to ultimately eliminate malaria and prevent its reemergence.
Key achievements
 The cumulative availability of effective, long-lasting insecticidal nets (LLINs) and insecticide-treated nets (ITNs)
for malaria prevention increased from 4.3 million in 2005 to 17.05 million in 2010 in the Region. Although the
overall coverage was less than 10 % of the population at risk, better planning ensured at least 80% coverage of
the villages targeted.
 The use of RDT for diagnosis increased from 1.4 million in 2005 to 15.2 million in 2010 in the Region.
 All countries with P. falciparum adopted ACT as the first-line treatment. Treatment courses of ACT procured increased
from 79 000 in 2005 to 3.9 million in 2010 in the SEA Region.
 Although there was not much change in the number of malaria cases reported, the malaria mortality rate declined
in the past decade due to improved coverage of early case detection and appropriate treatment.
 Bhutan, DPR Korea, Nepal and Sri Lanka are now moving towards malaria pre-elimination as they have significantly
reduced the malaria incidence.
 Maldives has sustained its malaria-free status since 1984.
 Malaria cases and deaths have declined markedly in Bangladesh and Thailand and transmission is now limited to
only a few districts. Improvements have also been noted in India, Indonesia, Myanmar and Timor-Leste.
 The overall financial support for malaria control, both from donors and governments of Member States has increased
markedly. The available fund per person at risk is just less than twenty cents and two thirds of this are from the
national governments of malaria-endemic countries.